We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 540 results
  1. Integrative approach using network pharmacology, bioinformatics, and experimental methods to explore the mechanism of cantharidin in treating colorectal cancer

    Cantharidin, a terpenoid produced by blister beetles, has been used in traditional Chinese medicine to treat various ailments and cancers. However,...

    Benchao Hou, **aomin Wang, ... Haiyun Liu in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 20 March 2024
  2. Cantharidin induces apoptosis of human triple negative breast cancer cells through mir-607-mediated downregulation of EGFR

    Background

    Triple negative breast cancer (TNBC) is a major subtype of breast cancer, with limited therapeutic drugs in clinical. Epidermal growth...

    Tianfeng Yang, Runze Yu, ... Yanmin Zhang in Journal of Translational Medicine
    Article Open access 05 September 2023
  3. Cantharidin and sodium fluoride attenuate the negative inotropic effects of carbachol in the isolated human atrium

    Carbachol, an agonist at muscarinic receptors, exerts a negative inotropic effect in human atrium. Carbachol can activate protein phosphatases (PP1...

    Rebecca Schwarz, Britt Hofmann, ... Joachim Neumann in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 06 October 2023
  4. Cantharidin increases the force of contraction and protein phosphorylation in isolated human atria

    Cantharidin, an inhibitor of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A), is known to increase the force of contraction and shorten...

    R. Schwarz, B. Hofmann, ... J. Neumann in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 25 April 2023
  5. Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma

    Background

    Cantharidin (CTD) is the active ingredient of Chinese medicine, which has been traditionally used in multiple cancers treatment, especially...

    Jia Yan, Yu min Gao, ... Gui tao Shi in BMC Cancer
    Article Open access 28 November 2023
  6. The protective effect of L-glutamine against acute Cantharidin-induced Cardiotoxicity in the mice

    Background

    Cantharidin (CTD) is a compound which have the potential to be exploited as an antitumor drug, and it has been demonstrated antitumor...

    Haozhen Shao, Lei Dong, ... Hongxuan Tong in BMC Pharmacology and Toxicology
    Article Open access 01 October 2020
  7. A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification

    Background

    Chronic hepatitis B virus (HBV) infection is the major etiology of hepatocellular carcinoma (HCC). However, the mechanism of hepatitis...

    Shenghao Li, Liyuan Hao, ... Luya Li in Infectious Agents and Cancer
    Article Open access 01 July 2023
  8. Norcantharidin toxicity profile: an in vivo murine study

    Norcantharidin (NCTD) is the demethylated analog of cantharidin, with allegedly reduced toxicity. However, there is still limited information...

    Gabriel Martínez-Razo, María Lilia Domínguez-López, ... Armando Vega-López in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 03 October 2022
  9. Lipidomics reveals serum lipid metabolism disorders in CTD-induced liver injury

    Background

    Cantharidin (CTD), the main toxic component of Mylabris , has been extensively used for tumor treatment in recent years. CTD-induced liver...

    Shan Li, **aotong Duan, ... Jianyong Zhang in BMC Pharmacology and Toxicology
    Article Open access 15 January 2024
  10. Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells

    Systemic lupus erythematosus (SLE) is a devastating autoimmune disorder associated with severe organ damage. The abnormality of T cell apoptosis is...

    Li-jun Du, Yu-xiang Feng, ... Yun Zhang in Acta Pharmacologica Sinica
    Article Open access 22 September 2021
  11. Further investigations on the influence of protein phosphatases on the signaling of muscarinic receptors in the atria of mouse hearts

    The vagal regulation of cardiac function involves acetylcholine (ACh) receptor activation followed by negative chronotropic and negative as well as...

    Ulrich Gergs, Silke Wackerhagen, ... Joachim Neumann in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 03 February 2024
  12. Bioassay-guided isolation of cantharidin from blister beetles and its anticancer activity through inhibition of epidermal growth factor receptor-mediated STAT3 and Akt pathways

    Cantharidin is an active constituent of blister beetles (cantharides) which have traditionally been used for cancer treatment. Several studies have...

    Jaemoo Chun, Min Kyoung Park, ... Yeong Shik Kim in Journal of Natural Medicines
    Article 24 July 2018
  13. Avian Toxins and Poisoning Mechanisms

    All around the world, there are species of birds that have developed the ability to acquire toxic chemicals in their bodies making them less...

    Kara A. Yeung, Peter R. Chai, ... Timothy B. Erickson in Journal of Medical Toxicology
    Article Open access 26 April 2022
  14. Altering phosphorylation in cancer through PP2A modifiers

    Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase integral to the regulation of many cellular processes. Due to the deregulation of...

    Hannah Johnson, Satya Narayan, Arun K. Sharma in Cancer Cell International
    Article Open access 06 January 2024
  15. Protective and therapeutic effects of Scutellaria baicalensis and its main active ingredients baicalin and baicalein against natural toxicities and physical hazards: a review of mechanisms

    Objectives

    Scutellaria baicalensis (SB) has been traditionally used to combat a variety of conditions ranging from ischemic heart disease to cancer....

    Ali Ahmadi, Zoha Mortazavi, ... Hossein Hosseinzadeh in DARU Journal of Pharmaceutical Sciences
    Article 23 July 2022
  16. Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges

    Breast cancer is globally the most common invasive cancer in women and remains one of the leading causes of cancer-related deaths. Surgery,...

    Chaochao Yu, Yi Li, ... Yingwen Zhang in Journal of Zhejiang University-SCIENCE B
    Article 09 July 2022
  17. Microfluidic Manufacturing of Niosomes

    The efficient delivery of therapeutic agents remains a formidable hurdle in the realm of medical applications, primarily due to issues such as...
    Alaa A. A. Aljabali, Murtaza M. Tambuwala, Mohammad A. Obeid in Microfluidics in Pharmaceutical Sciences
    Chapter 2024
  18. Heat Shock Factors in Protein Quality Control and Spermatogenesis

    Proper regulation of cellular protein quality control is crucial for cellular health. It appears that the protein quality control machinery is...
    Vinod K. Nelson, Sourav Paul, ... Mahadeb Pal in Oxidative Stress and Toxicity in Reproductive Biology and Medicine
    Chapter 2022
  19. Autophagy Suppression Accelerates Apoptosis Induced by Norcantharidin in Cholangiocarcinoma

    Norcantharidin is a cantharidin demethylated analog with antitumor effects in many tumors, including cholangiocarcinoma. Autophagy suppression is...

    Yun Wang, Wangjie Jiang, ... **angcheng Li in Pathology & Oncology Research
    Article 14 October 2019
  20. The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway

    Background

    Multiple myeloma (MM), an incurable disease owing to drug resistance, requires safe and effective therapies. Norcantharidin (NCTD), an...

    Yingcong Wang, Sanfeng Dong, ... Jumei Shi in Journal of Translational Medicine
    Article Open access 27 November 2023
Did you find what you were looking for? Share feedback.